Keith Kendall

Keith Kendall

Plus aucun poste en cours

Fortune : 3 M $ au 31/03/2024

66 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Keith J.
Kendall
served as President, Chief Executive Officer & Director at Aquestive Therapeutics, Inc. from 2014 to 2022.
Prior to that, he was Vice President & Managing Director at Hewlett-Packard Financial Services Co. from 1999 to 2006.
He also served as Non-Executive Director at Biodexa Pharmaceuticals Plc from 2010 to 2014.
Before his time at Hewlett-Packard, he was President at CIT Communications Finance Corp.
and NCR Credit Corp.
from 1985 to 1998.
Kendall holds an MBA from Pace University and an undergraduate degree from St. John's University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/03/2023 637 149 ( 0,71% ) 3 M $ 31/03/2024

Anciens postes connus de Keith Kendall

SociétésPosteFin
FEMASYS INC. Director/Board Member 08/11/2023
AQUESTIVE THERAPEUTICS, INC. Chief Executive Officer 17/05/2022
BIODEXA PHARMACEUTICALS PLC Director/Board Member 01/12/2014
Corporate Officer/Principal 01/06/2006
President -
Voir l'expérience en détail de Keith Kendall

Formation de Keith Kendall

Pace University Masters Business Admin
St. John's University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Keith Kendall

Relations

40

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
FEMASYS INC.

Electronic Technology

AQUESTIVE THERAPEUTICS, INC.

Health Technology

BIODEXA PHARMACEUTICALS PLC

Health Technology

Entreprise privées3

Commercial Services

Finance

NCR Credit Corp.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Keith Kendall